Therapeutic promises of Chlorogenic acid with special emphasis on its anti-obesity property.

Kumar R., et al.
Current molecular pharmacology, 2019

Abstract

Background

Chlorogenic acid (CGA) is a quinic acid conjugate of caffeic acid. It is an ester formed between caffeic acid and the 3-hydroxyl of L-quinic acid. This polyphenol is naturally present in substantial amount in the green coffee beans. Minor quantities of CGA are also reported in apples, eggplant, blueberries, tomatoes, strawberries and potatoes. CGA is reported to be beneficial in hypertension, hyperglycemia, antimicrobial, antitumor, memory enhancer, weight management etc. Further, it is also reported to have anticancer, antioxidant and anti-inflammatory activities. Since last decade, CGA drew public attention for its widely recommended use as medicine or natural food additive supplement for the management of obesity.

Objective

The current review explores the medicinal promises of CGA and emphasizes on its anti-obese property as reported by various scientific reports and publication.

Conclusion

CGA shows promises as an antioxidant, glycemic control agent, anti-hypertensive, anti-inflammatory, antimicrobial, neuro-protective and anti-obesity agent. It primarily activates the AMP-activated protein kinase, inhibits 3-hydroxy 3-methylglutaryl coenzyme-A reductase and strengthens the activity of carnitine palmitoyltransferase to control the obesity.

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Keywords

Chlorogenic acid; Coffee; Lipid; Medicinal activity; Obesity

PMID:31333144
Category:Weight Loss

The best supplements with Chlorogenic Acid in Weight Loss category: Fast Burn Extreme.

Articles similar to "Therapeutic promises of Chlorogenic acid with special emphasis on its anti-obesity property."

Previous article

Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.

Next article

Chlorogenic acid (CGA): A pharmacological review and call for further research.